MedTrace Logo

Postoperative Epidural Analgesia in Spine Fusion Surgery

NCT01838707 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-04-25

No results posted yet for this study

Summary

we aim to compare the analgesic effect of 0.125% bupivacaine HCL, 0.125% bupivacaine HCL + Morphine sulphate 3 mg, 0.125% bupivacaine HCL + Fentanyl 100 micro gram both at rest and mobilization maneuvers.

Conditions

Interventions

DRUG

0.125% Bupivacaine HCL @ 4-5 ml/h

DRUG

0.125% Bupivacaine HCL , Morphine sulphate @ 3 mg 3-5 ml/h

DRUG

0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Omnia A Abd El Raof, M.Sc. · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01838707 on ClinicalTrials.gov